We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · June 30, 2022

MRI-Guided Focused Ultrasound Focal Therapy for Patients With Intermediate-Risk Prostate Cancer

The Lancet Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet Oncology
MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study
Lancet Oncol 2022 Jun 14;[EPub Ahead of Print], B Ehdaie, CM Tempany, F Holland, DD Sjoberg, AS Kibel, QD Trinh, JC Durack, O Akin, AJ Vickers, PT Scardino, D Sperling, JYC Wong, B Yuh, DA Woodrum, LA Mynderse, SS Raman, AJ Pantuck, MH Schiffman, TD McClure, GA Sonn, P Ghanouni

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Advanced Prostate Cancer Center of Excellence

Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.

Further Reading